Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Biomarkers of Skin Melanoma Resistance to Targeted Therapy—Present State and Perspectives

6 May 2022

Abstract excerpt

Melanoma is the most aggressive skin cancer, the number of which is increasing worldwide every year. It is completely curable in its early stage and fatal when spread to distant organs. In addition to new therapeutic strategies, biomarkers are an important element in the successful fight against this cancer. At present, biomarkers are mainly used in diagnostics. Some biological indicators also allow the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to Cutaneous Melanoma Detection and Management
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35565444
DOI: 10.3390/cancers14092315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Biomarkers of Skin Melanoma Resistance to Targeted Therapy—Present State and PerspectivesPMID 35565444Read ↗

Molecular, Genetic Susceptibility and Immunotherapy of MelanomaSemantic proximity Read ↗

BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current KnowledgeSemantic proximity Read ↗

Advances in Melanoma: From Genetic Insights to Therapeutic InnovationsSemantic proximity Read ↗

Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma.Semantic proximity Read ↗

Resistance to Targeted Therapy and RASSF1A Loss in Melanoma: What Are We Missing?Semantic proximity Read ↗

Molecular Markers and Targets in Melanoma.Semantic proximity Read ↗

Unraveling the Wide Spectrum of Melanoma BiomarkersSemantic proximity Read ↗

Signal pathways of melanoma and targeted therapySemantic proximity Read ↗

Mitogen-Activated Protein Kinase Signaling Pathway in Cutaneous Melanoma: An Updated Review.Semantic proximity Read ↗

Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations.Semantic proximity Read ↗

Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.Semantic proximity Read ↗

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating BiomarkersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.